A study assessing the use of continuous glucose monitoring in patients with T1D shows significant reductions in A1c and diabetes distress, with or without a behavioral intervention.

A protocol designed for primary care increased weight loss across a quarter of a million people, but only 25% of those with a ...

More than 90% of patients achieved clinically meaningful weight reduction compared to placebo in a phase 3 trial of ecnoglutide.

One-year data suggest allogeneic stem cell-derived islet-cell therapy could become a future option for those with type 1 ...

The mostly rural, socio-economically disadvantaged state is a tough place to practice, but providers who provide cancer care ...

A study of 13 insulin-dependent ultra-trail runners reveals how extreme racing fosters self-mastery, social support, and ...

Zemcelpro provides an option for people with a hematologic malignancy who need a blood stem cell transplant but have no ...

The dapivirine ring was originally approved in July 2020 to reduce the risk for HIV-1 infection in women 18 years and older ...

EULAR now recommends moving directly to biologic or targeted synthetic disease-modifying antirheumatic drugs if the initial ...

Dupilumab has been approved by the FDA for the treatment bullous pemphigoid in adults, the manufacturer Regeneron announced.

In the context of new anti-obesity medications, the American College of Cardiology has issued a Scientific Statement updating ...

The combination of high temperatures and poor air quality has been linked to an increased risk for acute myocardial ...